Clinical Trial of the Use of Anakinra in Cytokine Storm Syndrome Secondary to Covid-19 (ANA-COVID-GEAS)

Clinical trial NCT04443881 · COMPLETED

Trial details

NCT number: NCT04443881
Sponsor: Fundacion Miguel Servet
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

COVID-19 Pnemonia

Start date: 2020-05-08
Primary completion: 2021-03-31
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.